News | July 01, 2021
Sun Pharma launches 'Sunkalp' on National Doctors' Day
Sun Pharma has committed Rs. 100 crores towards these initiatives
Sun Pharma has committed Rs. 100 crores towards these initiatives
Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture and sell certain generic lenalidomide capsules
The company expects to see steady performance led by new launches and gradual normalization post the scale-up in vaccination
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
Drop in revenue in the fourth quarter is normal as China is shut down for most of the quarter due to the Chinese New Year holiday
It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021
New agreement for three further production lines at Lonza’s site in Visp, Switzerland
The Department of Pharmaceuticals launched the PLI scheme for promoting domestic manufacturing of bulk drugs, with a financial outlay of Rs. 6,940 crore across 53 APIs over 6 years
Indian government is expecting pharmaceutical industry to fetch incremental sales worth Rs. 294,000 crore and exports up to Rs. 196,000 crore by FY 2027-28
The merger is in line with Solara’s strategy of accelerating growth via appropriate inorganic actions
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
